
Bill.com, which provides back-office software, has struck a deal to buy Divvy in a stock-and-cash transaction valued at about $2.5 billion. Utah-based Divvy’s platform puts expense-management software and smart corporate cards together.
Headquartered in San Jose, California, Bill.com provides cloud-based software that automates back-office financial operations for small and medium-sized businesses (SMBs).
The acquisition will further Bill’s “vision to transform SMB financial operations,” said René Lacerte, Bill.com CEO and founder. He added, in a press release, that both companies are driving “customers’ digital transformations.” He said the combined company’s “platform will provide more automation and real-time information to SMBs, enabling them to make more informed decisions.”
The release said that Bill.com has more than 115,000 customers. For its part, Divvy offers such services as automated payables and receivables to its more-than 7,500 SMB customers.
“We are excited to be joining forces with Bill.com to help SMBs grow and thrive by modernizing and transforming their financial operations,” said Blake Murray, Divvy CEO and co-founder. The deal will create a “one-stop-shop platform that our customers and the market have been asking for.”
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas